GeneSYS ID Inc fka GNID

[StockMedic1]

All this speculation is great, but the aggregate of the releases tells a much bigger picture than worrying about the trading price and volume over the last month. If you have to measure the company by daily performances, I suggest you are in the wrong company or are relying on the wrong metrics. I am sure we will know soon what happened and why BMAK is still there. I am sure the CEO will fully disclose things and what steps she is taking to punish them all. Thats one good thing about having a woman running the company, she doesn't do well in the old boys OTC scam club. I am waiting for more news so I can see the vision of where the company is going and better, how they are doing it.